<i>In vitro</i> evaluation of ganaplacide/lumefantrine combination against <i>Plasmodium falciparum</i> in a context of artemisinin resistance
All these in vitro results evidence that multi-drug resistant parasites currently in circulation in the field might not affect KAF156 efficacy, and are encouraging signs for KAF156 use in a triple ACT to preserve the use of artemisinins for as long as possible.
Authors
- Anne Robert (ORCID: https://orcid.org/0000-0002-9092-6776)
- Françoise Benoit‐Vical (ORCID: https://orcid.org/0000-0002-9468-4823)
- Marion Laurent (ORCID: https://orcid.org/0000-0002-9029-027X)
- Manel Ouji
- Jean‐Michel Augereau (ORCID: https://orcid.org/0000-0002-2847-1969)
- Michel Nguyen (ORCID: https://orcid.org/0000-0002-6496-0495)
- Thibaud Reyser
- Lucie Paloque (ORCID: https://orcid.org/0000-0003-0359-3959)
- Chinedu Ogbonnia Egwu (ORCID: https://orcid.org/0000-0003-3408-5471)
- Jeanne Manaranche
- Roxane Tressieres
- Maryam Salim
Institutions
- Centre National de la Recherche Scientifique (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Institut de Pharmacologie et de Biologie Structurale (FR)
- Laboratoire de Chimie de Coordination (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1093/jac/dkae300
- Citations
- 6
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 3.26
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Centre National de la Recherche Scientifique